Literature DB >> 29017059

Direct Activation of BAX by BTSA1 Overcomes Apoptosis Resistance in Acute Myeloid Leukemia.

Denis E Reyna1, Thomas P Garner1, Andrea Lopez1, Felix Kopp2, Gaurav S Choudhary3, Ashwin Sridharan3, Swathi-Rao Narayanagari4, Kelly Mitchell4, Baoxia Dong3, Boris A Bartholdy4, Loren D Walensky5, Amit Verma3, Ulrich Steidl4, Evripidis Gavathiotis6.   

Abstract

The pan class="Gene">BCL-2 family protein BAX is a central mediator of apoptosis. Overexpression of anti-apoptotic pan class="Gene">BCL-2 proteins contributes to tumor development and resistance to therapy by suppressing BAX and its activators. We report the discovery of BTSA1, a pharmacologically optimized BAX activator that binds with high affinity and specificity to the N-terminal activation site and induces conformational changes to BAX leading to BAX-mediated apoptosis. BTSA1-induced BAX activation effectively promotes apoptosis in leukemia cell lines and patient samples while sparing healthy cells. BAX expression levels and cytosolic conformation regulate sensitivity to BTSA1. BTSA1 potently suppressed human acute myeloid leukemia (AML) xenografts and increased host survival without toxicity. This study provides proof-of-concept for direct BAX activation as a treatment strategy in AML.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BAX; BAX activator; BCL-2 family; BH3; BTSA1; MOMP; apoptosis; cell death; leukemia; mitochondria

Mesh:

Substances:

Year:  2017        PMID: 29017059      PMCID: PMC5793879          DOI: 10.1016/j.ccell.2017.09.001

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  52 in total

1.  Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS.

Authors:  Laura Barreyro; Britta Will; Boris Bartholdy; Li Zhou; Tihomira I Todorova; Robert F Stanley; Susana Ben-Neriah; Cristina Montagna; Samir Parekh; Andrea Pellagatti; Jacqueline Boultwood; Elisabeth Paietta; Rhett P Ketterling; Larry Cripe; Hugo F Fernandez; Peter L Greenberg; Martin S Tallman; Christian Steidl; Constantine S Mitsiades; Amit Verma; Ulrich Steidl
Journal:  Blood       Date:  2012-06-21       Impact factor: 22.113

2.  Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia.

Authors:  Marina Konopleva; Rooha Contractor; Twee Tsao; Ismael Samudio; Peter P Ruvolo; Shinichi Kitada; Xingming Deng; Dayong Zhai; Yue-Xi Shi; Thomas Sneed; Monique Verhaegen; Maria Soengas; Vivian R Ruvolo; Teresa McQueen; Wendy D Schober; Julie C Watt; Tilahun Jiffar; Xiaoyang Ling; Frank C Marini; David Harris; Martin Dietrich; Zeev Estrov; James McCubrey; W Stratford May; John C Reed; Michael Andreeff
Journal:  Cancer Cell       Date:  2006-11       Impact factor: 31.743

3.  Developmental Regulation of Mitochondrial Apoptosis by c-Myc Governs Age- and Tissue-Specific Sensitivity to Cancer Therapeutics.

Authors:  Kristopher A Sarosiek; Cameron Fraser; Nathiya Muthalagu; Patrick D Bhola; Weiting Chang; Samuel K McBrayer; Adam Cantlon; Sudeshna Fisch; Gail Golomb-Mello; Jeremy A Ryan; Jing Deng; Brian Jian; Chris Corbett; Marti Goldenberg; Joseph R Madsen; Ronglih Liao; Dominic Walsh; John Sedivy; Daniel J Murphy; Daniel Ruben Carrasco; Shenandoah Robinson; Javid Moslehi; Anthony Letai
Journal:  Cancer Cell       Date:  2016-12-22       Impact factor: 31.743

Review 4.  Delving deeper: MCL-1's contributions to normal and cancer biology.

Authors:  Rhonda M Perciavalle; Joseph T Opferman
Journal:  Trends Cell Biol       Date:  2012-09-28       Impact factor: 20.808

Review 5.  Apoptosis and oncogenesis: give and take in the BCL-2 family.

Authors:  Fabien Llambi; Douglas R Green
Journal:  Curr Opin Genet Dev       Date:  2011-01-13       Impact factor: 5.578

6.  ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets.

Authors:  Andrew J Souers; Joel D Leverson; Erwin R Boghaert; Scott L Ackler; Nathaniel D Catron; Jun Chen; Brian D Dayton; Hong Ding; Sari H Enschede; Wayne J Fairbrother; David C S Huang; Sarah G Hymowitz; Sha Jin; Seong Lin Khaw; Peter J Kovar; Lloyd T Lam; Jackie Lee; Heather L Maecker; Kennan C Marsh; Kylie D Mason; Michael J Mitten; Paul M Nimmer; Anatol Oleksijew; Chang H Park; Cheol-Min Park; Darren C Phillips; Andrew W Roberts; Deepak Sampath; John F Seymour; Morey L Smith; Gerard M Sullivan; Stephen K Tahir; Chris Tse; Michael D Wendt; Yu Xiao; John C Xue; Haichao Zhang; Rod A Humerickhouse; Saul H Rosenberg; Steven W Elmore
Journal:  Nat Med       Date:  2013-01-06       Impact factor: 53.440

7.  Direct and selective small-molecule activation of proapoptotic BAX.

Authors:  Evripidis Gavathiotis; Denis E Reyna; Joseph A Bellairs; Elizaveta S Leshchiner; Loren D Walensky
Journal:  Nat Chem Biol       Date:  2012-05-27       Impact factor: 15.040

8.  Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia.

Authors:  Andrew W Roberts; Matthew S Davids; John M Pagel; Brad S Kahl; Soham D Puvvada; John F Gerecitano; Thomas J Kipps; Mary Ann Anderson; Jennifer R Brown; Lori Gressick; Shekman Wong; Martin Dunbar; Ming Zhu; Monali B Desai; Elisa Cerri; Sari Heitner Enschede; Rod A Humerickhouse; William G Wierda; John F Seymour
Journal:  N Engl J Med       Date:  2015-12-06       Impact factor: 91.245

9.  An Autoinhibited Dimeric Form of BAX Regulates the BAX Activation Pathway.

Authors:  Thomas P Garner; Denis E Reyna; Amit Priyadarshi; Hui-Chen Chen; Sheng Li; Yang Wu; Yogesh Tengarai Ganesan; Vladimir N Malashkevich; Emily H Cheng; Evripidis Gavathiotis
Journal:  Mol Cell       Date:  2016-07-14       Impact factor: 17.970

10.  Identification of an activation site in Bak and mitochondrial Bax triggered by antibodies.

Authors:  Sweta Iyer; Khatira Anwari; Amber E Alsop; Wai Shan Yuen; David C S Huang; John Carroll; Nicholas A Smith; Brian J Smith; Grant Dewson; Ruth M Kluck
Journal:  Nat Commun       Date:  2016-05-24       Impact factor: 14.919

View more
  39 in total

1.  Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment.

Authors:  Xufeng Chen; Christina Glytsou; Hua Zhou; Sonali Narang; Denis E Reyna; Andrea Lopez; Theodore Sakellaropoulos; Yixiao Gong; Andreas Kloetgen; Yoon Sing Yap; Eric Wang; Evripidis Gavathiotis; Aristotelis Tsirigos; Raoul Tibes; Iannis Aifantis
Journal:  Cancer Discov       Date:  2019-05-02       Impact factor: 39.397

2.  Topology of active, membrane-embedded Bax in the context of a toroidal pore.

Authors:  Stephanie Bleicken; Tufa E Assafa; Carolin Stegmueller; Alice Wittig; Ana J Garcia-Saez; Enrica Bordignon
Journal:  Cell Death Differ       Date:  2018-09-05       Impact factor: 15.828

3.  ICBS 2017 in Shanghai-Illuminating Life with Chemical Innovation.

Authors:  Qi Zhang; Jingyu Zhang; Evripidis Gavathiotis
Journal:  ACS Chem Biol       Date:  2018-05-02       Impact factor: 5.100

Review 4.  Mitochondria as multifaceted regulators of cell death.

Authors:  Florian J Bock; Stephen W G Tait
Journal:  Nat Rev Mol Cell Biol       Date:  2019-10-21       Impact factor: 94.444

5.  Overcoming resistance to mitochondrial apoptosis by BZML-induced mitotic catastrophe is enhanced by inhibition of autophagy in A549/Taxol cells.

Authors:  Zhaoshi Bai; Meiqi Gao; Xiaobo Xu; Huijuan Zhang; Jingwen Xu; Qi Guan; Qing Wang; Jianan Du; Zhengqiang Li; Daiying Zuo; Weige Zhang; Yingliang Wu
Journal:  Cell Prolif       Date:  2018-03-01       Impact factor: 6.831

Review 6.  Cell Death in the Lung: The Apoptosis-Necroptosis Axis.

Authors:  Maor Sauler; Isabel S Bazan; Patty J Lee
Journal:  Annu Rev Physiol       Date:  2018-11-28       Impact factor: 19.318

7.  Prognostic roles of miR-124-3p and its target ANXA7 and their effects on cell migration and invasion in hepatocellular carcinoma.

Authors:  Honghai Wang; Jun Mao; Yuhong Huang; Jun Zhang; Lin Zhong; Ying Wu; He Huang; Jiayu Yang; Yuanyi Wei; Jianwu Tang
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

Review 8.  Targeting apoptosis in cancer therapy.

Authors:  Benedito A Carneiro; Wafik S El-Deiry
Journal:  Nat Rev Clin Oncol       Date:  2020-03-23       Impact factor: 66.675

9.  Mitochondrial residence of the apoptosis inducer BAX is more important than BAX oligomerization in promoting membrane permeabilization.

Authors:  Tomomi Kuwana; Louise E King; Katia Cosentino; Julian Suess; Ana J Garcia-Saez; Andrew P Gilmore; Donald D Newmeyer
Journal:  J Biol Chem       Date:  2020-01-03       Impact factor: 5.157

10.  BAX-Depleted Retinal Ganglion Cells Survive and Become Quiescent Following Optic Nerve Damage.

Authors:  Ryan J Donahue; Margaret E Maes; Joshua A Grosser; Robert W Nickells
Journal:  Mol Neurobiol       Date:  2019-10-31       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.